Medigard selects site for trials
Thursday, 10 July, 2008
Medical device company Medigard [ASX; MGZ] will conduct clinical trials of its proprietary safety blood collection devices at Griffith University's Gold Coast campus.
The trials will be held at the university's Genomics Research Centre. 500 of the devices have been delivered to the centre for simulated clinical trials.
The trials are part of the company's FDA 510(k) application, a fast-tracking process for important, innovative or advanced medical devices.
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
